A full listing of Novartis clinical trials which also includes active and completed studies can be found at ClinicalTrials.gov.
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. These studies ensure that an investigative medicine is effective and safe, and rely entirely on patients and healthy volunteers. Learn more about clinical trials at Novartis including opportunities to get involved.
Participating in a Clinical Trial
About Clinical Trials
A clinical trial is a research study that is done to find out if a treatment can improve people`s health. A treatment can be a drug, medical device, medical procedure or a a change in a person`s behavior such as diet or exercise.
Information for Patients
Deciding to take part in a clinical trial is an important decision, and it is yours to make. Before enrolling in a clinical trial, you should learn as much as possible about the trial.
Why should I consider to participate in a clinical trial?
Clinical trials help to develop potential new medicines, discover if certain medicines work better than others and find new uses for already-approved medicines.
Inside the Four Phases of a Clinical Trial
We've partnered with CNN to explain the clinical trial process
Transparency
Our vision is to be a trusted leader in changing the practice of medicine. A big part of gaining this trust is being transparent – being open and clearly disclosing what we do, how we work and where we are successful.
Clinical Trials Results
The results of Novartis clinical trials are made publicly available through peer-reviewed publications and posting of results on the Novartis clinical trial results database and other online public databases.
Trial summaries for patients
Novartis provides trial summaries for patients from Phase 1 through 4 interventional trials for innovative products. A trial summary for patients is a trial result written in easier to understand language than the corresponding technical result summary. The trial summary for patients is provided in English and the local languages of the trial patients.
Clinial Trials in Numbers
Ethics and Diversity
Ethics
For every Novartis clinical trial our primary responsibility is to protect the safety, well-being and legal rights of all participants and ensure adherence to the highest ethical standards for clinical research.
Diversity
Diversity in clinical trials is integral to who we are at Novartis and we are working hard to improve both the diversity of patients enrolled in our clinical research and the investigators involved in our trials.
Resources for Healthcare Professionals and Researchers
Voluntary data sharing
Novartis is committed to sharing with qualified external researchers, access to patient-level data and clinical study reports from eligible studies.
Managed Access Programs
Managed Access makes investigational or unapproved treatments available to eligible patients with serious or life-threatening diseases.
Investigator Initiated Trials (IITs)
As part of our commitment to delivering innovative therapies to patients worldwide, Novartis believes in the need to support ethical independent clinical research conducted by qualified third-party investigators.
Country Resources
COVID-19 clinical trials
Novartis is sponsoring and co-sponsoring a number of coronavirus (COVID-19) clinical trials and participating in multiple research collaborations
Clinical Trials Stories
Building clinical trial diversity for long-term equit
Vas Narasimhan reflects on how to increase diversity in clinical trials
Turning the sound up on patient voices in lung cancer research and development
Patrice Matchaba shares how a lifetime of experience helped shape an effort to address healthcare disparities.
Demystifying clinical trials
A Novartis team couriers an experimental treatment across Europe to a patient as transit grinds to a halt